Skip to content
24/7NewsPaper
Back to feed
CChicago Business Journalbizjournals.com

Syntax Bio expands Series A to $14.4M, inks Mayo Clinic collaboration (opens original article in a new tab)

TL;DR

Syntax Bio expands Series A to $14.4M to advance stem cell therapies for Type 1 diabetes with Mayo Clinic collaboration

  • Syntax Bio raised $14.4 million in Series A expansion funding
  • Syntax Bio is advancing stem cell therapies for Type 1 diabetes
  • Syntax Bio has a collaboration with Mayo Clinic
Back to feedRead original

Conversation

No comments yet

Threaded discussion is coming next — this is where the community conversation about this story will live.